Oruka Therapeutics (ORKA) Earnings Date, Estimates & Call Transcripts $7.83 -1.09 (-12.22%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$7.74 -0.09 (-1.21%) As of 04/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Oruka Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 24Before Market OpensEstimatedActual EPS (Mar. 6) -$0.49 Beat By $0.19 Consensus EPS (Mar. 6) -$0.68 Oruka Therapeutics issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.49, which beat analysts' consensus estimates of -$0.68 by $0.19. With a trailing EPS of -$5.79, Oruka Therapeutics' earnings are expected to grow next year, from ($3.41) to ($2.92) per share. ORKA Upcoming EarningsOruka Therapeutics' next earnings date is estimated for Thursday, April 24, 2025, based off prior year's reporting schedules. Get Oruka Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oruka Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataORKA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ORKA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Oruka Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.41-$0.31-$0.37Q2 20253-$0.48-$0.37-$0.43Q3 20253-$0.52-$0.37-$0.45Q4 20253-$0.57-$0.46-$0.52FY 202512-$1.98-$1.51-$1.77Q1 20261-$1.31-$1.31-$1.31Q2 20261-$1.46-$1.46-$1.46 Remove Ads Oruka Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/24/2025(Estimated)-------3/6/2025Q4 2024-$0.68-$0.49+$0.19-$0.49--8/1/2024Q2 2024--$25.92 -$25.92-$2.16--4/25/2024Q1 2024--$20.16 -$20.16-$1.68--2/1/2024Q4 2023--$11.52 -$11.52-$0.96--10/18/2023Q3 2023--$14.40 -$14.40-$1.20--7/21/2023Q2 2023--$14.40 -$14.40-$1.20--4/24/2023Q1 2023--$12.96 -$12.96-$1.08-- Oruka Therapeutics Earnings - Frequently Asked Questions When is Oruka Therapeutics's earnings date? Oruka Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on ORKA's earnings history. Did Oruka Therapeutics beat their earnings estimates last quarter? In the previous quarter, Oruka Therapeutics (NASDAQ:ORKA) reported ($0.49) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.19. Learn more on analysts' earnings estimate vs. ORKA's actual earnings. How much profit does Oruka Therapeutics generate each year? Oruka Therapeutics (NASDAQ:ORKA) has a recorded net income of -$5.34 million. ORKA has generated -$5.79 earnings per share over the last four quarters. What is Oruka Therapeutics's EPS forecast for next year? Oruka Therapeutics's earnings are expected to grow from ($3.41) per share to ($2.92) per share in the next year. More Earnings Resources from MarketBeat Related Companies Vera Therapeutics Earnings Results Immunocore Earnings Results ANI Pharmaceuticals Earnings Results Schrödinger Earnings Results IDEAYA Biosciences Earnings Results Amphastar Pharmaceuticals Earnings Results Indivior Earnings Results Wave Life Sciences Earnings Results ARS Pharmaceuticals Earnings Results Calliditas Therapeutics AB (publ) Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Remove Ads This page (NASDAQ:ORKA) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORKA Stock Free ORKA Stock Alerts